维康药业
(300878)
| 流通市值：13.78亿 | | | 总市值：25.66亿 |
| 流通股本：7774.25万 | | | 总股本：1.45亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 226,178,966.78 | 330,162,451.72 | 195,805,987.76 | 440,148,133.77 |
| 应收票据及应收账款 | 279,781,084.25 | 212,130,988.57 | 325,819,997.66 | 326,739,985.73 |
| 应收账款 | 279,781,084.25 | 212,130,988.57 | 325,819,997.66 | 326,739,985.73 |
| 应收款项融资 | 45,093,476.33 | 52,836,688.91 | 15,295,899.57 | 9,059,664.29 |
| 预付款项 | 8,006,156.38 | 4,799,157.41 | 25,837,114.86 | 20,976,342.28 |
| 其他应收款合计 | 12,416,630.5 | 11,554,269.55 | 6,365,726.39 | 3,213,078.09 |
| 存货 | 123,350,811 | 153,784,689.7 | 158,871,664.81 | 137,098,582.28 |
| 其他流动资产 | 12,530,032.44 | 23,927,015.34 | 13,559,291.26 | 9,561,250.66 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 707,357,157.68 | 1,034,759,890.59 | 982,555,682.31 | 946,797,037.1 |
| 非流动资产: | | | | |
| 长期股权投资 | 1,555,547.12 | 1,552,415.14 | - | - |
| 其他非流动金融资产 | 25,000,000 | 25,000,000 | 25,000,000 | 25,000,000 |
| 投资性房地产 | 8,675,842.65 | 5,431,760.06 | 5,344,575.2 | 5,420,135.42 |
| 固定资产 | 516,219,781.12 | 529,833,584.44 | 527,382,359.81 | 530,522,427.26 |
| 在建工程 | 331,797,815.14 | 301,907,569.27 | 439,249,456.63 | 407,930,821.45 |
| 使用权资产 | 26,264,344.22 | 27,516,261.13 | 22,945,144.06 | 25,877,944.38 |
| 无形资产 | 35,198,110.28 | 35,667,116.93 | 36,163,751.74 | 36,641,812.15 |
| 商誉 | 27,049,069.09 | 27,083,681.1 | 27,096,263.6 | 27,152,905.12 |
| 长期待摊费用 | 4,517,686.06 | 5,074,278.41 | 5,598,716.87 | 6,176,005.68 |
| 递延所得税资产 | 26,000,427.84 | 27,069,590.53 | 12,495,108.69 | 14,165,841.54 |
| 其他非流动资产 | 28,359,302.67 | 25,740,383.28 | 813,000 | 813,000 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,030,637,926.19 | 1,011,876,640.29 | 1,102,088,376.6 | 1,079,700,893 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,737,995,083.87 | 2,046,636,530.88 | 2,084,644,058.91 | 2,026,497,930.1 |
| 流动负债: | | | | |
| 短期借款 | 150,000 | 261,903,936.11 | 289,164,333.34 | 259,497,305.55 |
| 应付票据及应付账款 | 70,491,710.41 | 101,116,031.89 | 91,600,035.47 | 93,147,943.07 |
| 其中：应付票据 | 11,543,717.16 | 17,809,444.85 | 21,136,939.9 | 14,134,259.23 |
| 应付账款 | 58,947,993.25 | 83,306,587.04 | 70,463,095.57 | 79,013,683.84 |
| 预收款项 | 564,592.65 | 317,484.96 | - | - |
| 合同负债 | 9,162,836.98 | 14,377,541.09 | 15,411,212.9 | 8,444,447.56 |
| 应付职工薪酬 | 8,115,732.7 | 12,410,830.14 | 8,269,506.15 | 7,567,198.55 |
| 应交税费 | 7,073,976.77 | 5,437,966.56 | 2,038,772.68 | 3,259,562.19 |
| 其他应付款合计 | 22,000,099.81 | 23,594,456.29 | 6,963,671.83 | 7,687,448.06 |
| 一年内到期的非流动负债 | 10,252,675.49 | 10,208,326.25 | 11,374,427.68 | 11,763,857.68 |
| 其他流动负债 | 1,190,382.63 | 1,863,335.21 | 2,003,246.9 | 1,095,427.6 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 129,002,007.44 | 431,229,908.5 | 426,825,206.95 | 392,463,190.26 |
| 非流动负债: | | | | |
| 长期借款 | 171,821,582.05 | 149,946,486.94 | 124,589,474.13 | 105,115,346.16 |
| 租赁负债 | 10,723,327.61 | 13,184,739.02 | 6,133,221.42 | 9,206,329.49 |
| 递延收益 | 41,925,407 | 42,833,479.85 | 36,061,552.7 | 36,969,625.55 |
| 递延所得税负债 | 1,881,965.48 | 2,033,116.93 | 6,223,517.81 | 6,280,159.33 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 226,352,282.14 | 207,997,822.74 | 173,007,766.06 | 157,571,460.53 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 355,354,289.58 | 639,227,731.24 | 599,832,973.01 | 550,034,650.79 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 144,790,322 | 144,790,322 | 144,790,322 | 144,790,322 |
| 资本公积 | 680,765,027.86 | 680,765,027.86 | 680,765,027.86 | 680,765,027.86 |
| 减:库存股 | 49,998,351.8 | - | - | - |
| 盈余公积 | 65,014,532.55 | 65,014,532.55 | 60,990,520.77 | 60,990,520.77 |
| 未分配利润 | 523,406,829.36 | 499,237,970.16 | 581,122,987.4 | 576,393,007.3 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,363,978,359.97 | 1,389,807,852.57 | 1,467,668,858.03 | 1,462,938,877.93 |
| 少数股东权益 | 18,662,434.32 | 17,600,947.07 | 17,142,227.87 | 13,524,401.38 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,382,640,794.29 | 1,407,408,799.64 | 1,484,811,085.9 | 1,476,463,279.31 |
| 负债和股东权益合计 | 1,737,995,083.87 | 2,046,636,530.88 | 2,084,644,058.91 | 2,026,497,930.1 |
| 公告日期 | 2024-04-29 | 2024-04-29 | 2023-10-30 | 2023-08-29 |
| 审计意见(境内) | | 保留意见 | | |